Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 08:00 ET | Source: Biomea Fusion, Inc.

Biomea Fusion to Present Poster Presentations at ObesityWeek®2025

SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present...
October 15, 2025 10:22 ET | Source: Research and Markets

Anti-Obesity Drugs Market Report 2025 - Industry Trends, Global Forecasts and Key Players

Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Anti-Obesity Drugs Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Active Compound Used, Mechanism of Action,...
July 14, 2025 06:04 ET | Source: Research and Markets

Europe Glucagon-like Peptide-1 (GLP-1) Agonists Research Report 2025 | Market to Reach $14.34 Billion by 2034, Driven by Innovative R&D, Strategic Collaborations, and Drug Formulation Advancements

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The...
July 14, 2025 05:56 ET | Source: Research and Markets

GLP-1 Agonists Drug Pipeline Analysis Market Report 2025 | Next-generation GLP-1 Agonists Pave the Way for Diabetes and Obesity Management

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Agonists Drug Pipeline Analysis Report 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.The GLP-1 Agonists Drug Pipeline...
July 10, 2025 10:52 ET | Source: Research and Markets

United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report 2025-2034 | Expanding Clinical Trials and Increasing Insurance Coverage to Boost Growth Prospects

Dublin, July 10, 2025 (GLOBE NEWSWIRE) -- The "United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's...
July 08, 2025 07:39 ET | Source: Research and Markets

Anti-Obesity Drugs Market Research and Forecast Report 2025 | Market to Surpass $120 Billion by 2034 - Increased Strategic Merger and Initiatives to Meet Rising Demand

Dublin, July 08, 2025 (GLOBE NEWSWIRE) -- The "Anti-Obesity Drugs Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The anti-obesity drugs market was...
March 18, 2025 05:33 ET | Source: Research and Markets

GLP-1 Market Industry Trends and Global Forecasts 2024-2035: Over 150 GLP-1 Drug Candidates in Development for Multiple Indications, Type 2 Diabetes and Obesity Drive GLP-1 Drug Development Boom

Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist,...
March 17, 2025 05:38 ET | Source: Research and Markets

Anti-Obesity Drugs Market Industry Trends, Sales Forecast, Key Players and Global Forecasts to 2035: Semaglutide & Tirzepatide Lead the Global Anti-Obesity Drug Market Boom

Dublin, March 17, 2025 (GLOBE NEWSWIRE) -- The "Anti-Obesity Drugs Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Mechanism of Action, Type of...
October 01, 2024 04:35 ET | Source: Research and Markets

$49.3 Bn GLP-1 Markets 2024-2035 with Boehringer Ingelheim, Eli Lilly, Novo Nordisk Dominating

Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "GLP-1 Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type...
September 27, 2024 09:19 ET | Source: Research and Markets

Diabetes Drugs Global Strategic Business Report 2024: Market to Surpass $205 Billion by 2030 - Development of GLP-1 Receptor Agonists Expands Treatment Options

Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Diabetes Drugs...